Evidence map›Paper›PMID 40207486›Full record

SynthesisJournal of the American Heart Association2025

Invasive Strategy With Intended Percutaneous Coronary Intervention Versus Conservative Treatment in Older People With ST-Segment-Elevation Myocardial Infarction: A Meta-Analysis.

Sascha Macherey-Meyer, David Dilley, Sebastian Heyne, Max Maria Meertens, Richard Julius Nies, Samuel Lee, Christoph Adler, Stephan Baldus, Ingo Eitel, Thomas Stiermaier and 2 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sascha Macherey-MeyerFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0002-7080-6611
David DilleyFaculty of Medicine University Schleswig-Holstein, University Hospital Lübeck Lübeck Germany.
Sebastian HeyneFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0002-1581-9954
Max Maria MeertensFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0002-7746-8723
Richard Julius NiesFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0002-1336-6031
Samuel LeeFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0001-6768-7079
Christoph AdlerFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0002-1045-2743
Stephan BaldusFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine University of Cologne Cologne Germany.ORCID 0000-0001-8259-1737
Ingo EitelMedical Clinic II University Heart Center Lübeck, University Schleswig-Holstein Lübeck Germany.ORCID 0000-0002-6442-246X
Thomas StiermaierMedical Clinic II University Heart Center Lübeck, University Schleswig-Holstein Lübeck Germany.ORCID 0000-0003-1957-3741
Christian FrerkerMedical Clinic II University Heart Center Lübeck, University Schleswig-Holstein Lübeck Germany.ORCID 0000-0003-0226-0888
Tobias SchmidtMedical Clinic II University Heart Center Lübeck, University Schleswig-Holstein Lübeck Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients ≥80 years old were underrepresented or excluded from landmark trials demonstrating the superiority of primary percutaneous coronary intervention (PCI) in ST-segment-elevation myocardial infarction. The current meta-analysis assessed the effects of an invasive strategy with intended PCI compared with conservative treatment in older people (≥80 years) with ST-segment-elevation myocardial infarction.

methodsA structured literature search was performed. The primary outcome was overall survival. Secondary outcome analyses included but were not limited to 30-day and 1-year mortality.

resultsThirteen studies reporting on 102 158 older adults were included. Of these, 31 629 (31%) were assigned to PCI and 70 529 (69%) were treated conservatively. The overall survival was 76.5% in PCI and 67.2% in conservative treatment at the time of longest available follow-up (odds ratio [OR], 2.18 [95% CI, 1.79-2.66],

conclusionsThis meta-analysis indicates a potential underuse of PCI in older adults with ST-segment-elevation myocardial infarction. PCI was advantageous in short- and long-term survival, but these results were affected by confounding. Nonetheless, every second patient not referred for invasive treatment survived at least 1 year. These findings have hypothesis generating implications, but they indicate ageism and emphasize that PCI should not be automatically withheld in older patients.

Indexed as

Conservative TreatmentPercutaneous Coronary InterventionST Elevation Myocardial InfarctionAged, 80 and overAge FactorsFemaleHumansMaleRisk FactorsTime FactorsTreatment Outcomecentenariansnonagenariansoctogenariansoptimal medical therapypercutaneous coronary interventionSTEMI

Identifiers

PMID40207486
PMCPMC12132903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.